XML 59 R47.htm IDEA: XBRL DOCUMENT v3.23.4
Stockholders' Equity - Stock-based Compensation (Details) - USD ($)
$ / shares in Units, $ in Thousands
 3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Stockholders' Equity        
Stock-based compensation expense $ 7,328 $ 7,239 $ 14,417 $ 14,416
RSU        
Stockholders' Equity        
Unrecognized compensation cost $ 23,800   $ 23,800  
Weighted-average period     2 years 3 months 18 days  
Shares        
Nonvested at the beginning of the period (in shares)     455,515  
Granted (in shares)     331,278  
Vested (in shares)     (384,614)  
Forfeited (in shares)     (5,226)  
Nonvested at the end of the period (in shares) 396,953   396,953  
Weighted-Average Fair Value        
Nonvested at the beginning of the period (in dollars per share)     $ 85.15  
Granted (in dollars per share)     95.23  
Vested (in dollars per share)     79.51  
Forfeited (in dollars per share)     84.66  
Nonvested at the end of the period (in dollars per share) $ 99.03   $ 99.03  
Stock Options        
Stockholders' Equity        
Unrecognized compensation cost $ 1,200   $ 1,200  
Weighted-average period     2 years 4 months 24 days  
Number of Options        
Outstanding at the beginning of the period (in shares)     83,677  
Granted (in shares)     22,438  
Exercised (in shares)     (14,489)  
Expired or forfeited (in shares)     (4,375)  
Outstanding at the end of the period (in shares) 87,251   87,251  
Exercisable at the end of the period (in shares) 42,856   42,856  
Weighted Average Exercise Price        
Outstanding at the beginning of the period (in dollars per share)     $ 87.09  
Granted (in dollars per share)     119.45  
Exercised (in dollars per share)     81.93  
Expired or forfeited (in dollars per share)     86.09  
Outstanding at the end of the period (in dollars per share) $ 96.32   $ 96.32  
Weighted-Average Remaining Contractual Term        
Outstanding at the end of the period     7 years 8 months 12 days  
Exercisable at the end of the period     6 years 1 month 6 days  
Aggregate Intrinsic Value        
Outstanding at the end of the period $ 2,856   $ 2,856  
Exercisable at the end of the period $ 1,797   $ 1,797  
Performance-based restricted stock units        
Shares        
Granted (in shares)     75,988 110,811
Performance-based restricted stock units | Minimum        
Shares        
Share based compensation arrangement by percentage of shares units awarded     0.00%  
Performance-based restricted stock units | Maximum        
Shares        
Share based compensation arrangement by percentage of shares units awarded     376.00%  
OSI Plans        
Stockholders' Equity        
Shareholders approved increased the shares under OSI Plan 2,400,000   2,400,000  
Shares available for grant 2,500,000   2,500,000  
OSI Plans | RSU        
Stockholders' Equity        
Number of shares available for grant reduced for each award granted     1.87  
Number of shares available for grant increased for each award forfeited and returned     1.87  
Cost of goods sold        
Stockholders' Equity        
Stock-based compensation expense $ 255 241 $ 487 $ 457
Selling, general and administrative        
Stockholders' Equity        
Stock-based compensation expense 6,945 6,870 13,676 13,710
Research and development        
Stockholders' Equity        
Stock-based compensation expense $ 128 $ 128 $ 254 $ 249